Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gabapentin Vs. Lorazepam in Alcohol Withdrawal

NCT00229125 is registered in ClinicalTrials.gov with National Institute on Alcohol Abuse and Alcoholism (NIAAA) as lead sponsor.

NCT NCT00229125
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00229125 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gabapentin Vs. Lorazepam in Alcohol Withdrawal
Lead sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2001
Completion date
September 30, 2005
Enrollment
160
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol withdrawal syndrome(aws)